CABG MEDICAL, INC. INVESTMENT AGREEMENTInvestment Agreement • May 9th, 2005 • Cabg Medical Inc • Surgical & medical instruments & apparatus • Minnesota
This Investment Agreement (the “Agreement”) is made as of March 22, 2005 by and between CABG Medical, Inc., a Minnesota corporation (the “Company”) with its principal office at 14505 21st Avenue North, Minneapolis, Minnesota 55447, and Angiotech Pharmaceuticals, Inc., a corporation organized and existing under the laws of the Province of British Columbia (“Angiotech”) with its principal office at 1618 Station Street, Vancouver, British Columbia, Canada V6A 1B6.
LICENSE AGREEMENTLicense Agreement • May 9th, 2005 • Cabg Medical Inc • Surgical & medical instruments & apparatus • Washington
This License Agreement, effective as of March 22, 2005 (the “Effective Date”), is by and between Angiotech Pharmaceuticals, Inc., a corporation organized and existing under the laws of the Province of British Columbia, Canada (“Angiotech Parent”), Angiodevice International GmbH, a corporation organized and existing under the laws of Switzerland (“Angiodevice”), Angiotech International AG, a corporation organized and existing under the laws of Switzerland (“Angiotech International”), Angiotech BioCoatings Corp., a corporation organized and existing under the laws of the State of New York, USA (“Angiotech BioCoatings”) and CABG Medical, Inc., a corporation organized and existing under the laws of the State of Minnesota, USA (“CABG”). Each of the parties hereto is referred to herein as “Party” and collectively as the “Parties”.
